Stocks Higher as In...
Health Care: Drugs
Eli Lilly and Company (LLY: NYSE)
$52.35 -0.01 | -0.02%
06/18/13 - 04:02 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with LLY
- Portfolio NameUser Type
- ProRenaissance Technologies
- ContributorHigh Volume Technicals for ...
- Contributor8 Stocks With Big Dividends...
- ContributorStocks Rising On Unusual Vo...
- ContributorRocket Stocks for the Week ...
- UserJS&JH
- Contributor5 Bullish Stocks to Buy on ...
- UserBG Stockpickr Wish List
- UserStock Interests, Ideas & Re...
- Contributor7 High-Yield Stocks With Bu...
Latest LLY Headlines from TheStreet
- 5 Stocks Raising The Drugs Industry Higher 06.17.13 | 01:06 pm
- Cramer's 6 Stocks in 60 Seconds: GME LLY RBCN AXP HRL CLH 06.14.13 | 10:06 am
- 5 Drugs Stocks Dragging The Industry Down 06.11.13 | 01:06 pm
- Eli Lilly And Company (LLY): Today's Featured Health Care Laggard 06.05.13 | 05:06 pm
- Analysts' Actions: ALGN EXC JCI LLY MRK 05.28.13 | 08:05 am
- Eli Lilly And Company (LLY): Today's Featured Drugs Laggard 05.24.13 | 05:05 pm
- Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY) 05.21.13 | 10:05 am
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Eli Lilly And Company (LLY): Today's Featured Drugs Winner 05.15.13 | 05:05 pm
- 4 Stocks Going Ex-Dividend Tomorrow: GIL, ACC, ADM, LLY 05.13.13 | 10:05 am
Press Releases for LLY
- Lilly Acquires Novel Tau Tangle Diagnostic Program To Bolster Alzheimer's Disease Research And Development - PR Newswire 04.17.13 | 08:04 am
- Lilly Announces Positive Results Of Phase III Trials Of Dulaglutide In Type 2 Diabetes - PR Newswire 04.16.13 | 08:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Lilly Confirms Date And Conference Call For First-Quarter 2013 Financial Results Announcement - PR Newswire 04.03.13 | 04:04 pm
- Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations - PR Newswire 04.02.13 | 08:04 am
- European Medicines Agency Accepts Marketing Authorization Application For Boehringer Ingelheim And Eli Lilly And Company's Empagliflozin*, An Investigational Type 2 Diabetes Treatment - PR Newswire 03.26.13 | 11:03 am
- Boehringer Ingelheim And Eli Lilly And Company Submit New Drug Application To FDA For Empagliflozin, An Investigational Type 2 Diabetes Treatment - PR Newswire 03.25.13 | 08:03 am
- Boehringer Ingelheim And Lilly Initiate MARLINA Clinical Trial To Evaluate Use Of Tradjenta® (linagliptin) Tablets In Patients With Type 2 Diabetes And Albuminuria - PR Newswire 03.19.13 | 08:03 am
- New Study Of Cialis® (tadalafil) Tablets Co-administered With Finasteride Meets Primary Endpoint In Men With Lower Urinary Tract Symptoms Of Benign Prostatic Hyperplasia - PR Newswire 03.18.13 | 11:03 am
- New Superiority Trial Showed LIVALO® (pitavastatin) 4 Mg Provided Significantly Greater LDL-C Reduction In HIV-Infected Adults With Dyslipidemia Versus Pravastatin 40 Mg - PR Newswire 03.07.13 | 06:03 am
Partner Headlines for LLY
- Parexel Trying To Clear Three-Weeks-Tight Buy Point - Investor's Business Daily 06.11.13 | 06:06 pm
- Drug Company Profits Set to Increase from Additions to DSM-5 (LLY, NVS, PFE) - Benzinga 06.06.13 | 08:06 am
- CVR Energy, Warner Chilcott and Other Top Performers in May - Benzinga 06.02.13 | 09:06 am
- Patent Challenge from Perrigo - Analyst Blog - Zacks 06.01.13 | 12:06 am
- Stocks Market News for May 30, 2013 - Market News - Zacks 05.30.13 | 03:05 pm
- Smithfield fails to light up Wall St - Financial Times 05.29.13 | 04:05 pm
- PreMarket Info Recap for May 28, 2013 - Benzinga 05.28.13 | 09:05 am
- Oncogenex to Advance OGX-427 Development - Analyst Blog - Zacks 05.24.13 | 10:05 pm
- US doctors paid $1bn by top drug companies - Financial Times 05.22.13 | 07:05 pm
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying - Benzinga 05.18.13 | 03:05 pm
